Buspirone vs. Haloperidol: A Double-Blind Trial for Agitation in a Nursing Home Population With Alzheimer's Disease

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Marc CantillonMarcel Bahro

Abstract

The authors report on a pilot double-blind comparison of buspirone with haloperidol in the treatment of agitation manifested by physical tension and motor activity in Alzheimer's disease (AD). A group of 26 nursing home residents underwent a 10-week comparison of 15 mg buspirone (n = 12) vs. 1.5 mg haloperidol (n = 14) per day. Tension and anxiety decreased to a greater extent in those patients who were treated with buspirone. Although it is not possible to draw definitive conclusions from a treatment study that does not include a placebo group, these findings suggest the potential value of further clinical research on buspirone in managing agitation in AD.

Citations

May 7, 1999·Journal of Geriatric Psychiatry and Neurology·B G Pollock, B H Mulsant
Jan 1, 2003·Expert Review of Neurotherapeutics·Abhilash K Desai, George T Grossberg
Jul 20, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dilip V JesteKristine Yaffe
Jan 11, 2019·Journal of Clinical Psychopharmacology·Shinichiro OchiShu-Ichi Ueno
Nov 1, 2001·The Cochrane Database of Systematic Reviews·E LonerganJ Colford
Feb 6, 1999·Journal of Clinical Psychopharmacology·J T Apter, L A Allen
Dec 8, 2010·Periodontology 2000·Jonas A RodriguesKlaus W Neuhaus
Jan 1, 1997·New Directions for Mental Health Services·P TariotA P Porsteinsson
Nov 5, 2003·Expert Opinion on Pharmacotherapy·Hubert H FernandezBrian R Ott
Nov 21, 2007·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Nathan Herrmann, Krista L Lanctôt
Oct 23, 2012·International Psychogeriatrics·Dallas P SeitzDavid K Conn
Nov 5, 2015·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Jun 22, 2002·The Cochrane Database of Systematic Reviews·E LonerganJ Colford
Mar 10, 2001·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·N Herrmann
Nov 30, 2000·Current Treatment Options in Neurology·A S Schachter, K L Davis
Oct 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Nathan HerrmannPaul G Lysy
Jan 27, 2017·International Psychogeriatrics·Maria R Santa CruzSuzanne Holroyd
Jul 24, 2021·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Shinichiro OchiShu-Ichi Ueno

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here